Corporate news

01.09.2025
Ad-hoc: Marinomed Biotech AG: Agreement on the key terms of the issue of a secured EUR 2.5mn convertible bond
05.06.2025
Marinomed Biotech AG announces partnership for Budesolv in Switzerland
08.05.2025
Marinomed Biotech AG announces results for the first quarter of 2025
09.04.2025
Marinomed Biotech AG: Launch of new moisturizing Carragelose eye drops in Austria
Public Relations
Marinomed Biotech AG
Hovengasse 25
2100 Korneuburg, Austria
+43 2262 90300
office@marinomed.com